BRPI0813176A2 - Moléculas e composições par ainibir fator edema e adenilil ciclase - Google Patents

Moléculas e composições par ainibir fator edema e adenilil ciclase

Info

Publication number: BRPI0813176A2
Authority: BR; Brazil
Prior art keywords: adenylil; cyclase; molecules; compositions; factor
Prior art date: 2007-06-15

Application number

BRPI0813176-7A2A

Other languages

English (en)

Inventor

Catherine H Schein

Deliang Chen

Scott R Gilbertson

Maria Estrella-Jimmenez

Jian Gao

Mary A Walter

Johnny W Peterson

Original Assignee

Mission Pharma Co

Univ Texas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-15

Filing date

2008-06-13

Publication date

2014-12-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40468705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0813176(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-06-13 Application filed by Mission Pharma Co, Univ Texas filed Critical Mission Pharma Co

2014-12-30 Publication of BRPI0813176A2 publication Critical patent/BRPI0813176A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0813176-7A2A 2007-06-15 2008-06-13 Moléculas e composições par ainibir fator edema e adenilil ciclase BRPI0813176A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94437507P	2007-06-15	2007-06-15
US3526908P	2008-03-10	2008-03-10
PCT/US2008/066898 WO2009038842A2 (en)	2007-06-15	2008-06-13	Methods and compositions to inhibit edema factor and adenylyl cyclase

Publications (1)

Publication Number	Publication Date
BRPI0813176A2 true BRPI0813176A2 (pt)	2014-12-30

Family

ID=40468705

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0813176-7A2A BRPI0813176A2 (pt)	2007-06-15	2008-06-13	Moléculas e composições par ainibir fator edema e adenilil ciclase

Country Status (12)

Country	Link
US (2)	US8003692B2 (pt)
EP (1)	EP2166841A4 (pt)
CN (1)	CN101784274A (pt)
AR (1)	AR067850A1 (pt)
AU (1)	AU2008302667B2 (pt)
BR (1)	BRPI0813176A2 (pt)
CA (1)	CA2692004C (pt)
CL (1)	CL2008001782A1 (pt)
CO (1)	CO6270184A2 (pt)
DO (1)	DOP2009000272A (pt)
MX (1)	MX2009013676A (pt)
WO (1)	WO2009038842A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101680026A (zh) *	2007-01-12	2010-03-24	康乃尔研究基金会有限公司	作为真核病原体感染治疗的新型靶的腺苷酰环化酶
US9017681B2 (en) *	2007-01-12	2015-04-28	Cornell Research Foundation, Inc.	Adenylyl cyclases as novel targets for antibactrial interventions
MX2009013676A (es) *	2007-06-15	2010-06-01	Mission Pharma Co	Metodos y composiciones para inhibir el factor de edema y la adenilil ciclasa.
WO2010011607A1 (en) *	2008-07-22	2010-01-28	Promega Corporation	Adp detection based luminescent phosphotransferase or atp hydrolase assay
AU2010231058A1 (en) *	2009-03-31	2011-11-10	Renascience Co., Ltd.	Plasminogen activator inhibitor-1 inhibitor
CA2860672A1 (en) *	2012-01-06	2013-07-11	University Of South Florida	Compositions, methods of use, and methods of treatment
US10092537B2 (en)	2013-04-15	2018-10-09	Renascience Co., Ltd.	Use for PAI-1 inhibitor
US9677117B2 (en)	2014-10-08	2017-06-13	Promega Corporation	Bioluminescent succinate detection assay
CN105218343B (zh) *	2015-10-26	2017-03-22	乐普药业股份有限公司	一种3‑溴环己‑2‑烯‑1‑酮的合成方法
KR102672910B1 (ko) *	2017-01-10	2024-06-07	오웬-배리 파머소티컬즈 인코포레이티드	항경련 화합물
PT3684767T (pt)	2017-09-22	2024-07-29	Jubilant Epipad LLC	Compostos heterocíclicos como inibidores de pad
US10882821B1 (en)	2017-09-26	2021-01-05	The Board Of Trustees Of The Leland Stanford Junior University	Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes
CA3076476A1 (en)	2017-10-18	2019-04-25	Jubilant Epipad LLC	Imidazo-pyridine compounds as pad inhibitors
US11629135B2 (en)	2017-11-06	2023-04-18	Jubilant Prodell Llc	Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
AU2018372211B2 (en)	2017-11-24	2023-02-02	Jubilant Episcribe LLC,	Heterocyclic compounds as PRMT5 inhibitors
JP7279063B6 (ja)	2018-03-13	2024-02-15	ジュビラントプローデルエルエルシー	Ｐｄ１／ｐｄ－ｌ１相互作用／活性化の阻害剤としての二環式化合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4066834A (en) *	1974-01-24	1978-01-03	Miles Laboratories, Inc.	Cycloalkenyl analogues of prostaglandins E
US4222944A (en) *	1978-07-31	1980-09-16	Hoffmann-La Roche Inc.	Halo-3-dibenzofuran alkanonitriles
AU736347B2 (en) *	1996-09-04	2001-07-26	Warner-Lambert Company	Compounds for and a method of inhibiting matrix metalloproteinases
AU3665700A (en) *	1999-03-22	2000-10-09	Charterhouse Therapeutics Ltd.	Chemical compounds and their uses
AU2001274858A1 (en) *	2000-06-08	2001-12-17	Board Of Regents, The University Of Texas System	Heterocycle derivatives and methods of use for treating anthrax infection
US6887880B2 (en) *	2000-11-20	2005-05-03	Millennium Pharmaceuticals, Inc.	Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions, and method of use thereof
AU2002217316A1 (en) *	2001-01-03	2002-07-30	Medpharma Plc	Use of terpenes for the treatment of digestive tract infections
DE10123163A1 (de) *	2001-05-09	2003-01-16	Gruenenthal Gmbh	Substituierte Cyclohexan-1,4-diaminderivate
KR20040022238A (ko) *	2001-08-09	2004-03-11	오노 야꾸힝 고교 가부시키가이샤	카르복실산 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
CA2469976A1 (en) *	2001-12-14	2003-06-26	Alan Michael Happe	Improvements in pharmaceutical compositions
US20030157159A1 (en) *	2002-01-15	2003-08-21	Franklin Lanny Udell	Prevention and treatment of digestive tract infections
US20030224403A1 (en) *	2002-02-27	2003-12-04	Popov Serguei G.	Lethal toxin cytopathogenicity and novel approaches to anthrax treatment
WO2003072532A1 (en) *	2002-02-28	2003-09-04	Japan Tobacco Inc.	Ester compound and medicinal use thereof
AU2003269317B2 (en) *	2002-10-23	2009-10-29	Glenmark Pharmaceuticals Ltd.	Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
JP2007516203A (ja) *	2003-07-09	2007-06-21	バイオリポックスエービー	炎症の治療に有用なインドール類
WO2005028467A1 (en) *	2003-09-15	2005-03-31	Anadys Pharmaceuticals, Inc.	Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
CN104788328B (zh) *	2004-06-24	2017-09-12	沃泰克斯药物股份有限公司	Atp‑结合弹夹转运蛋白的调控剂
US20080096848A1 (en) *	2004-09-29	2008-04-24	Cytovia Inc.	Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis
US7091231B2 (en) *	2004-12-10	2006-08-15	Allergan, Inc.	12-Aryl prostaglandin analogs
WO2007076055A2 (en) *	2005-12-22	2007-07-05	Entremed, Inc.	Compositions and methods comprising proteinase activated receptor antagonists
EP2029594B1 (en) *	2006-05-23	2010-10-20	NeuroSearch A/S	Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
MX2009013676A (es) *	2007-06-15	2010-06-01	Mission Pharma Co	Metodos y composiciones para inhibir el factor de edema y la adenilil ciclasa.

2008
- 2008-06-13 MX MX2009013676A patent/MX2009013676A/es active IP Right Grant
- 2008-06-13 CN CN200880024507A patent/CN101784274A/zh active Pending
- 2008-06-13 WO PCT/US2008/066898 patent/WO2009038842A2/en not_active Ceased
- 2008-06-13 BR BRPI0813176-7A2A patent/BRPI0813176A2/pt not_active Application Discontinuation
- 2008-06-13 EP EP08832293.8A patent/EP2166841A4/en not_active Withdrawn
- 2008-06-13 AU AU2008302667A patent/AU2008302667B2/en not_active Ceased
- 2008-06-13 CA CA2692004A patent/CA2692004C/en not_active Expired - Fee Related
- 2008-06-13 US US12/139,212 patent/US8003692B2/en not_active Expired - Fee Related
- 2008-06-16 CL CL2008001782A patent/CL2008001782A1/es unknown
- 2008-06-17 AR ARP080102569A patent/AR067850A1/es unknown
2009
- 2009-12-03 DO DO2009000272A patent/DOP2009000272A/es unknown
2010
- 2010-01-12 CO CO10002271A patent/CO6270184A2/es active IP Right Grant
2011
- 2011-06-07 US US13/154,923 patent/US20120010233A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US8003692B2 (en)	2011-08-23
EP2166841A2 (en)	2010-03-31
CO6270184A2 (es)	2011-04-20
WO2009038842A2 (en)	2009-03-26
CL2008001782A1 (es)	2008-11-03
CA2692004A1 (en)	2009-03-26
MX2009013676A (es)	2010-06-01
CA2692004C (en)	2013-04-09
DOP2009000272A (es)	2010-02-15
CN101784274A (zh)	2010-07-21
AR067850A1 (es)	2009-10-28
WO2009038842A3 (en)	2009-12-30
US20090093519A1 (en)	2009-04-09
AU2008302667B2 (en)	2014-07-10
US20120010233A1 (en)	2012-01-12
AU2008302667A1 (en)	2009-03-26
EP2166841A4 (en)	2014-05-07

Publication	Publication Date	Title
BRPI0813176A2 (pt)	2014-12-30	Moléculas e composições par ainibir fator edema e adenilil ciclase
LTPA2018014I1 (lt)	2018-12-10	Farmacinė kompozicija 514
PL2214679T3 (pl)	2019-09-30	Kompozycje kortykosteroidów
SMT201500176B (it)	2015-09-07	Composizioni e metodi per inibire l'espressione ditranstiretina
BRPI0913806A2 (pt)	2015-10-20	"composição"
EP2200550A4 (en)	2016-01-27	TOPICAL GLYCOPYRROLATE FORMULATIONS
BRPI0810634A2 (pt)	2014-10-07	Composições fungicidas
PL2150575T3 (pl)	2017-05-31	Kompozycja powłoki antyadhezyjnej i sposób jej wytwarzania
DK2185157T3 (da)	2021-03-08	Dhea-sammensætninger til at behandle menopause
EP2280916A4 (en)	2014-07-23	HYDROCHLORFLUOROLEFINZUSAMMENSETZUNGEN
BRPI0815407A2 (pt)	2014-09-30	Composições e métodos para controlar nematódeos
BRPI0817473A2 (pt)	2017-05-16	plataforma de aplicativo para executar aplicativos
BRPI0909174A2 (pt)	2015-08-25	Composição cosméticas para proporcionar peliculas super hidrofóbicas
BRPI0813775A2 (pt)	2015-01-06	Composição
BRPI0818007A2 (pt)	2015-11-03	composição para regular o metabolismo lipídico
BRPI0913945A2 (pt)	2016-09-27	agentes anti-inflamatórios
EP2037872A4 (en)	2012-10-10	COMPOSITIONS COMPRISING BITULONIC ACID
ATE528048T1 (de)	2011-10-15	Schweisshemmende/desodorierende zusammensetzung
LT2966175T (lt)	2019-08-26	Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
PL2301525T3 (pl)	2014-01-31	Preparat ibuprofenu do stosowania miejscowego
BRPI0814165A2 (pt)	2015-01-20	Composições tópicas endoparasiticidas
BRPI0810557A2 (pt)	2016-07-19	composição
BRPI0811274A2 (pt)	2014-10-07	Composição
DK2280706T3 (da)	2013-02-04	Lipasa-aktiverende lipoproteinsammensætninger omfattende benzenderivater
EP2318306A4 (en)	2012-09-12	NANOCOMPOSITES

Legal Events

Date	Code	Title	Description
2015-06-09	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2015-09-08	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]